source
- FDA approves brexu-cel for adult relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted approval for brexu-cel as a treatment option for adult patients with relapsed or refractory mantle cell lymphoma. Dr. Luhua (Michael) Wang discuss…
- iECURE’s early gene-therapy success in a baby fails to replicate in larger trialEarly last year iECURE reported that its experimental gene therapy appeared to cure an infant suffering from a severe genetic disorder. The company has now released data from a follow-up study tha…